Cargando…

Deep venous thrombosis in the antenatal period in a large cohort of pregnancies from western India

BACKGROUND: Deep venous thrombosis (DVT) is an important complication in the peripartal and postpartal period. METHODS: We followed up prospectively the prevalence of DVT in 34720 prenatal mothers between June 2002 and July 2006 attending the antenatal clinics of two major hospitals in Mumbai, India...

Descripción completa

Detalles Bibliográficos
Autores principales: Vora, Sonal, Ghosh, Kanjaksha, Shetty, Shrimati, Salvi, Vinita, Satoskar, Purnima
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1950495/
https://www.ncbi.nlm.nih.gov/pubmed/17610719
http://dx.doi.org/10.1186/1477-9560-5-9
_version_ 1782134548396507136
author Vora, Sonal
Ghosh, Kanjaksha
Shetty, Shrimati
Salvi, Vinita
Satoskar, Purnima
author_facet Vora, Sonal
Ghosh, Kanjaksha
Shetty, Shrimati
Salvi, Vinita
Satoskar, Purnima
author_sort Vora, Sonal
collection PubMed
description BACKGROUND: Deep venous thrombosis (DVT) is an important complication in the peripartal and postpartal period. METHODS: We followed up prospectively the prevalence of DVT in 34720 prenatal mothers between June 2002 and July 2006 attending the antenatal clinics of two major hospitals in Mumbai, India. Thirty two women (0.1%) presented for the first time with symptomatic DVT i.e. 17 in the first trimester, 6 in the second and 9 in the third trimester of pregnancy. Nine had history of fetal loss while in the remaining twenty three there was no history of fetal loss. RESULTS: The evaluation of both acquired and heritable thrombophilia showed a conglomeration of thrombophilia in this group when compared to 100 normal pregnant women who have given birth to at least one healthy baby with no history of fetal death, DVT or other obstetrical complications. The relative risks for all the antiphospholipid antibodies (APA) studied i.e lupus anticoagulant (LA), IgG/IgM antibodies for cardiolipin (ACA), β2 glycoprotein 1 (β2 GP 1) and annexin V were significantly higher in women with pregnancy associated DVT (RR 7.4 95% CI 4.3–11.3 P < 0.05). Among the genetic thrombophilia markers studied, Protein S (PS) deficiency was the strongest risk factor (RR 5.00 95% CI 3.02–5.00 P < 0.05) followed by factor V Leiden (FVL) mutation (RR 4.57 95% CI 2.23–4.57 P < 0.05) and PAI 4G/4G homozygosity (RR 3.24 95% CI 1.85–5.12 P < 0.05). Protein C (PC) and endothelial protein C receptor (EPCR) 23 bp insertion polymorphism was also increased in the patient group as compared to controls but the difference was not statistically significant. The MTHFR C677T, fibrinogen gene β448 Arg/Lys polymorphisms were not significantly different from the normal controls, while antithrombin III (AT III) deficiency and PT G20210A polymorphism were absent in both controls and patients. Two or more risk factors were present in 22 out of 32 cases (68.75%). CONCLUSION: We conclude that the prevalence of DVT in India is more or less similar to other reports published and both acquired and heritable thrombophilia show strong association with DVT associated with pregnancy.
format Text
id pubmed-1950495
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-19504952007-08-22 Deep venous thrombosis in the antenatal period in a large cohort of pregnancies from western India Vora, Sonal Ghosh, Kanjaksha Shetty, Shrimati Salvi, Vinita Satoskar, Purnima Thromb J Original Clinical Investigation BACKGROUND: Deep venous thrombosis (DVT) is an important complication in the peripartal and postpartal period. METHODS: We followed up prospectively the prevalence of DVT in 34720 prenatal mothers between June 2002 and July 2006 attending the antenatal clinics of two major hospitals in Mumbai, India. Thirty two women (0.1%) presented for the first time with symptomatic DVT i.e. 17 in the first trimester, 6 in the second and 9 in the third trimester of pregnancy. Nine had history of fetal loss while in the remaining twenty three there was no history of fetal loss. RESULTS: The evaluation of both acquired and heritable thrombophilia showed a conglomeration of thrombophilia in this group when compared to 100 normal pregnant women who have given birth to at least one healthy baby with no history of fetal death, DVT or other obstetrical complications. The relative risks for all the antiphospholipid antibodies (APA) studied i.e lupus anticoagulant (LA), IgG/IgM antibodies for cardiolipin (ACA), β2 glycoprotein 1 (β2 GP 1) and annexin V were significantly higher in women with pregnancy associated DVT (RR 7.4 95% CI 4.3–11.3 P < 0.05). Among the genetic thrombophilia markers studied, Protein S (PS) deficiency was the strongest risk factor (RR 5.00 95% CI 3.02–5.00 P < 0.05) followed by factor V Leiden (FVL) mutation (RR 4.57 95% CI 2.23–4.57 P < 0.05) and PAI 4G/4G homozygosity (RR 3.24 95% CI 1.85–5.12 P < 0.05). Protein C (PC) and endothelial protein C receptor (EPCR) 23 bp insertion polymorphism was also increased in the patient group as compared to controls but the difference was not statistically significant. The MTHFR C677T, fibrinogen gene β448 Arg/Lys polymorphisms were not significantly different from the normal controls, while antithrombin III (AT III) deficiency and PT G20210A polymorphism were absent in both controls and patients. Two or more risk factors were present in 22 out of 32 cases (68.75%). CONCLUSION: We conclude that the prevalence of DVT in India is more or less similar to other reports published and both acquired and heritable thrombophilia show strong association with DVT associated with pregnancy. BioMed Central 2007-07-04 /pmc/articles/PMC1950495/ /pubmed/17610719 http://dx.doi.org/10.1186/1477-9560-5-9 Text en Copyright © 2007 Vora et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Clinical Investigation
Vora, Sonal
Ghosh, Kanjaksha
Shetty, Shrimati
Salvi, Vinita
Satoskar, Purnima
Deep venous thrombosis in the antenatal period in a large cohort of pregnancies from western India
title Deep venous thrombosis in the antenatal period in a large cohort of pregnancies from western India
title_full Deep venous thrombosis in the antenatal period in a large cohort of pregnancies from western India
title_fullStr Deep venous thrombosis in the antenatal period in a large cohort of pregnancies from western India
title_full_unstemmed Deep venous thrombosis in the antenatal period in a large cohort of pregnancies from western India
title_short Deep venous thrombosis in the antenatal period in a large cohort of pregnancies from western India
title_sort deep venous thrombosis in the antenatal period in a large cohort of pregnancies from western india
topic Original Clinical Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1950495/
https://www.ncbi.nlm.nih.gov/pubmed/17610719
http://dx.doi.org/10.1186/1477-9560-5-9
work_keys_str_mv AT vorasonal deepvenousthrombosisintheantenatalperiodinalargecohortofpregnanciesfromwesternindia
AT ghoshkanjaksha deepvenousthrombosisintheantenatalperiodinalargecohortofpregnanciesfromwesternindia
AT shettyshrimati deepvenousthrombosisintheantenatalperiodinalargecohortofpregnanciesfromwesternindia
AT salvivinita deepvenousthrombosisintheantenatalperiodinalargecohortofpregnanciesfromwesternindia
AT satoskarpurnima deepvenousthrombosisintheantenatalperiodinalargecohortofpregnanciesfromwesternindia